PWM
NTRP

Paulson Wealth Management’s Neurotrope, Inc. Common NTRP Stock Holding History

Paulson Wealth Management’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-9,169
Closed -$65K – 580
2017
Q4 		$65K Buy
+9,169
New +$53.4K 0.06% 177

Other funds holding NTRP

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tanaka Capital Management New York $59.9M AUM
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Paulson Wealth Management's NTRP Position: Q1 2018 in Review

Paulson Wealth Management sold out of Neurotrope, Inc. Common (NTRP) in Q1 2018, closing a stake of 9,169 shares — an estimated $65K sold.

Paulson Wealth Management first reported a position in NTRP in Q4 2017 and held it in 1 quarter. The position peaked at $65K in Q4 2017. 18 funds tracked by Wall St. Rank hold NTRP as of Q1 2018.

  • Paulson Wealth Management reported no remaining Neurotrope, Inc. Common position as of Q1 2018 after selling out during the quarter.
  • Paulson Wealth Management sold 9,169 Neurotrope, Inc. Common shares in Q1 2018, an estimated $65K.
  • Paulson Wealth Management first reported a position in Neurotrope, Inc. Common in Q4 2017 and held it in 1 quarter.
  • Paulson Wealth Management's Neurotrope, Inc. Common position peaked at $65K in Q4 2017.
  • 18 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q1 2018.

Based on Paulson Wealth Management's 13F filing for Q1 2018, filed 2 May 2018.